Cargando…
Association Between Copayment and Adherence to Medications for Pulmonary Arterial Hypertension
BACKGROUND: Pharmacologic treatment for pulmonary arterial hypertension (PAH) improves exercise capacity, functional class, and hemodynamic indexes. However, monthly prescription costs often exceed $4000. We examined associations between (1) medication copayment and (2) annual household income with...
Autores principales: | Schikowski, Erin M., Swabe, Gretchen, Chan, Stephen Y., Magnani, Jared W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750087/ https://www.ncbi.nlm.nih.gov/pubmed/36370005 http://dx.doi.org/10.1161/JAHA.122.026620 |
Ejemplares similares
-
Association of patient copayment and medication adherence in systemic lupus erythematosus
por: Lomanto Silva, Raisa, et al.
Publicado: (2023) -
Association between income and likelihood of right heart catheterization in individuals with pulmonary hypertension: A US claims database analysis
por: Schikowski, Erin M., et al.
Publicado: (2022) -
Hypertension, Prescription Drug Copayments, and Drug Therapy Adherence
por: Curtiss, Frederic R.
Publicado: (2003) -
Income and antiplatelet adherence following percutaneous coronary intervention
por: LaRosa, Anna R., et al.
Publicado: (2022) -
Assessment of Depression and Adherence to Guideline-Directed Medical Therapies Following Percutaneous Coronary Intervention
por: Lapa, Matthew E., et al.
Publicado: (2022)